Deborah Marsh

Professor Deborah Marsh is a cancer cell and molecular biologist leading the Translational Oncology Group at the University of Technology Sydney (UTS) since 2018. She holds the position of Discipline Leader for Medical Science in the School of Life Sciences. Her career spans over 25 years, including postdoctoral research at Harvard Medical School and leadership roles at the Kolling Institute. She has published over 145 papers, with an h-index of 53, focusing on ovarian cancer, familial cancer syndromes, and epigenetics.

Education & Training:

• BScAgr (hons), University of Sydney (1989)
• PhD, University of Sydney (1996)
• Postdoctoral Fellow, Dana-Farber Cancer Institute, Boston (1996-1999)

Research Interests: Professor Marsh specializes in ovarian cancer mechanisms, including drug repurposing, epigenetic regulation, and familial cancer syndromes like Hyperparathyroidism Jaw Tumour Syndrome. She also leads bio-banking initiatives and explores non-coding RNA roles in malignancies.

Awards:

• Premier’s Award for Outstanding Cancer Research (2006)
• Young Tall Poppy Award (2005)
• Rotary Club Vocational Excellence Award (2012)

Grants & Collaborations: Her work is funded by NHMRC, ARC, and industry partnerships. She leads projects on ARID1A-mutant ovarian cancer and drug repurposing. She serves on editorial boards for journals like Endocrine-Related Cancer and Cancers.

Labs & Teams: Coordinates the Translational Oncology Group at UTS, focusing on 3D modeling for personalized medicine and ovarian cancer therapies.